You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
GPCR antagonists as anti-Ebola virus entry inhibitors
SBC: MICROBIOTIX, INC. Topic: RDESCRIPTION provided by applicant Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as biosafety level agents Currently there is no effective vaccine or therapeutic treatment against f ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI
SBC: ASTROCYTE PHARMACEUTICALS INC. Topic: 105DESCRIPTION provided by applicant Traumatic brain injuries TBI are an area of significant unmet need with no approved therapeutics and a national burden of $ billion annually Astrocyte Pharmaceuticals is developing a small molecule pharmaceutical agent that would be administered by intravenous injection by emergency responders or a medical professional within hours of injury to limit n ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Phase IIB: Portable Device for Telecare Monitoring of Elderly People
SBC: BIOSENSICS LLC Topic: NIADESCRIPTION provided by applicant We propose to further develop field test and commercialize a reliable and robust sensor technology that allows the objective assessment of daily physical activity risk of falling frailty and activity organization among older adults in he home and community This is a Phase IIB STTR application During Phases Iandamp II BioSensics LLC in collaboration wit ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Novel filovirus entry inhibitors based on a pseudo-symmetrical biphenyl core
SBC: MICROBIOTIX, INC. Topic: RDESCRIPTION provided by applicant Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as biosafety level agents Currently there is no effective vaccine or therapeutic treatment against f ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Lipoprotein synthesis inhibitors for multi-drug resistant Gram-negative therapy
SBC: MICROBIOTIX, INC. Topic: NIAIDDESCRIPTION provided by applicant The increasing prevalence of drug resistant bacterial infections highlights the critical medical need for new agents that are not susceptible to existing resistance mechanisms Few new agents are in development for Gram negative bacteria which take up small molecules sparingly and efflux most compounds that reach the periplasm A particularly problematic group ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Predictive High-Fidelity Modeling Capability for High-Brightness Photoinjectors
SBC: Gnosys Systems Inc. Topic: 06a"High brightness and high average power Free Electron Lasers known as x-ray FELs, developed by DOE, are intently desired by the scientific community for their unique capabilities and for the opportunities they enable in the medical and biological sciences, such as imaging biological molecules or chemical reactions. Beam optics codes (particularly Particle-in-Cell codes) couple non-uniformity and s ...
STTR Phase II 2015 Department of Energy -
Methodology for Attrition Evaluation of Oxygen Carriers in Chemical Looping Systems
SBC: ENVERGEX LLC Topic: 11dExisting methodologies for attrition evaluation of oxygen carriers in Chemical Looping Combustion systems do not adequately reflect the unique process conditions to which oxygen carriers are exposed, specifically high temperatures and cyclically reacting oxidizing and reducing atmospheres. This proposed Small Business Innovation Research (SBIR/STTR) project targets the development of novel equipme ...
STTR Phase II 2015 Department of Energy -
Ionomer Dispersion Impact on Advanced Fuel Cell and Electrolyzer Performance and Durability
SBC: GINER INC Topic: 09bThe non-aqueous ionomer dispersion technology invented at Los Alamos National Laboratory (LANL) has demonstrated great potential to significantly improve the lifetime of proton exchange membrane (PEM) fuel cells and electrolyzers. However, further validation and improvements are needed to make this technology commercially viable. The overall objective of this project is to further devel ...
STTR Phase II 2015 Department of Energy -
A novel drug detection assay using fluorescent biosensor technology
SBC: GLSynthesis Inc. Topic: 300DESCRIPTION provided by applicant This phase project has as its overall objectives to design engineer optimize and implement a novel genetically encoded fluorescent drug sensor FDS based on F rster Resonance Energy Transfer FRET by exploiting conformational rearrangements induced by drug interactions with human serum albumin SA SA is uniquely suited for a general drug sensor beca ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses
SBC: IQ MEDICAL IMAGING LLC Topic: 102DESCRIPTION provided by applicant The neurofibromatoses NFs including NF NF and schwannomatosis are a group of autosomal dominant neurogenetic disorders characterized by a predisposition in virtually of patients to develop multiple nerve sheath tumors The determination of tumor burden on magnetic resonance imaging MRI images is crucial for the management of NF patients which is ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health